Seoul, South Korea

Byoung Se Lee

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 42(Granted Patents)


Location History:

  • Incheon, KR (2013 - 2015)
  • Seoul, KR (2017 - 2024)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Byoung Se Lee: Innovator in Radiopharmaceuticals

Introduction

Byoung Se Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of radiopharmaceuticals, particularly in the diagnosis and treatment of prostate cancer. With a total of 6 patents to his name, Lee's work is at the forefront of medical innovation.

Latest Patents

One of his latest patents is a PSMA-targeted radiopharmaceutical for diagnosing and treating prostate cancer. This invention relates to a pharmaceutical composition capable of targeting PSMA, which is crucial for effective cancer treatment. The compound includes a glutamine-urea-lysine structure coupled with a radioactive metal-coupled chelator, designed to minimize nonspecific coupling in vivo. This innovation aims to reduce radiation exposure to normal tissues while enhancing the accumulation of the treatment in prostate cancer cells. Another notable patent involves a process for producing fluorinated compounds using an alcohol solvent with unsaturated hydrocarbons. This method allows for the high-yield production of organofluoro compounds, making it suitable for the automated synthesis of F-labeled radiopharmaceuticals.

Career Highlights

Throughout his career, Byoung Se Lee has worked with notable companies such as FutureChem Co., Ltd and Piramal Imaging. His expertise in radiopharmaceuticals has positioned him as a key player in the industry, contributing to advancements that have the potential to improve cancer treatment outcomes.

Collaborations

Lee has collaborated with esteemed colleagues, including Dae Yoon Chi and So Young Chu. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of radiopharmaceuticals.

Conclusion

Byoung Se Lee's contributions to the field of radiopharmaceuticals demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight the importance of targeted therapies in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…